The microarray scanners market size has grown strongly in recent years. It will grow from $1 billion in 2025 to $1.08 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of genomics research activities, growth in academic and research funding, increasing use of microarray technologies, rising demand for gene expression analysis, advancements in fluorescence detection methods.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine research, rising investments in biotechnology and pharmaceutical R&D, expansion of large-scale genomic studies, growing integration of ai-driven data analysis, increasing demand for high-throughput research tools. Major trends in the forecast period include increasing adoption of high-resolution fluorescence scanners, rising use in genomic and proteomic research, growing integration with data analysis software, expansion of automated sample processing, enhanced focus on multiplex detection.
The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.
Major companies operating in the microarray scanners market are focusing on the development of innovative products, such as advanced microarray platforms, to maintain their competitive position in the market. An advanced microarray platform is a high-throughput technology that allows the simultaneous analysis of thousands of genes, proteins, or biomarkers on a single chip, offering improved sensitivity, specificity, and data accuracy. For example, in June 2023, MARGenomics Private Ltd., a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform representing a significant advancement in microarray technology. The platform is notable for being the first in Europe and the United States to obtain regulatory approval for diagnostic use, highlighting its potential impact on clinical diagnostics and research. With its capability to deliver high-resolution genomic data, the system is expected to support and advance personalized medicine approaches across multiple therapeutic areas.
In May 2024, New York Blood Center Enterprises (NYBCe), a United States-based healthcare and biotechnology research organization, entered into a partnership with Thermo Fisher Scientific. Through this collaboration, the two organizations sought to jointly develop the Applied Biosystems Axiom BloodGenomiX Array and Reporter Software, a next-generation, high-throughput solution designed to enable more accurate blood genotyping and improve transfusion safety. Thermo Fisher Scientific is a United States-based technology and life sciences company.
Major companies operating in the microarray scanners market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation.
North America was the largest region in the microarray scanners market in 2025. The regions covered in the microarray scanners market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microarray scanners market by increasing costs of imported optical components, lasers, sensors, electronic modules, and precision manufacturing equipment. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported high-end scanners, while Asia-Pacific faces cost pressures on exported research instruments. These tariffs are increasing capital expenditure for laboratories and delaying equipment upgrades. However, they are also encouraging regional manufacturing, localized component sourcing, and development of cost-optimized microarray scanning solutions.
The microarray scanners market research report is one of a series of new reports that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microarray scanners play a crucial role in molecular biology and genetics research, specifically for the analysis of microarrays. Microarrays are arrays of microscopic spots containing immobilized DNA, RNA, proteins, or other molecules on solid surfaces such as glass slides or silicon chips. These scanners are utilized to measure the fluorescent regions of DNA microarrays, providing detailed insights into the simultaneous activity of numerous genes.
The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.
The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The microarray scanners market size is expected to see strong growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing adoption of precision medicine research, rising investments in biotechnology and pharmaceutical R&D, expansion of large-scale genomic studies, growing integration of ai-driven data analysis, increasing demand for high-throughput research tools. Major trends in the forecast period include increasing adoption of high-resolution fluorescence scanners, rising use in genomic and proteomic research, growing integration with data analysis software, expansion of automated sample processing, enhanced focus on multiplex detection.
The anticipated growth in the microarray scanner market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting three months or more and having the potential to worsen over time, can be effectively studied using microarray scanners. These devices enable the assessment of gene expression patterns, allowing researchers to delve into the molecular mechanisms underlying chronic diseases and identify potential biomarkers for diagnosis, prognosis, and treatment. According to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant increase from 71.522 million in 2020. Thus, the growing prevalence of chronic diseases is a key driver for the expansion of the microarray scanner market.
Major companies operating in the microarray scanners market are focusing on the development of innovative products, such as advanced microarray platforms, to maintain their competitive position in the market. An advanced microarray platform is a high-throughput technology that allows the simultaneous analysis of thousands of genes, proteins, or biomarkers on a single chip, offering improved sensitivity, specificity, and data accuracy. For example, in June 2023, MARGenomics Private Ltd., a Spain-based company, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform representing a significant advancement in microarray technology. The platform is notable for being the first in Europe and the United States to obtain regulatory approval for diagnostic use, highlighting its potential impact on clinical diagnostics and research. With its capability to deliver high-resolution genomic data, the system is expected to support and advance personalized medicine approaches across multiple therapeutic areas.
In May 2024, New York Blood Center Enterprises (NYBCe), a United States-based healthcare and biotechnology research organization, entered into a partnership with Thermo Fisher Scientific. Through this collaboration, the two organizations sought to jointly develop the Applied Biosystems Axiom BloodGenomiX Array and Reporter Software, a next-generation, high-throughput solution designed to enable more accurate blood genotyping and improve transfusion safety. Thermo Fisher Scientific is a United States-based technology and life sciences company.
Major companies operating in the microarray scanners market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, Hitachi High-Tech Corporation, Innopsys Inc., PerkinElmer Inc., VWR International LLC, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Tecan Group AG, Huron Technologies International Inc., Miltenyi Biotec B.V. & Co. KG, Luminex Corporation, Molecular Devices LLC, CapitalBio Technology Inc., Berthold Technologies GmbH & Co. KG, RayBiotech Inc., Scienion AG, Oxford Gene Technology IP Limited, Applied Microarrays Inc., Arrayit Corporation.
North America was the largest region in the microarray scanners market in 2025. The regions covered in the microarray scanners market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microarray scanners market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the microarray scanners market by increasing costs of imported optical components, lasers, sensors, electronic modules, and precision manufacturing equipment. Research institutes and biotechnology companies in North America and Europe are most affected due to dependence on imported high-end scanners, while Asia-Pacific faces cost pressures on exported research instruments. These tariffs are increasing capital expenditure for laboratories and delaying equipment upgrades. However, they are also encouraging regional manufacturing, localized component sourcing, and development of cost-optimized microarray scanning solutions.
The microarray scanners market research report is one of a series of new reports that provides microarray scanners market statistics, including microarray scanners industry global market size, regional shares, competitors with a microarray scanners market share, detailed microarray scanners market segments, market trends and opportunities, and any further data you may need to thrive in the microarray scanners industry. This microarray scanners market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Microarray scanners play a crucial role in molecular biology and genetics research, specifically for the analysis of microarrays. Microarrays are arrays of microscopic spots containing immobilized DNA, RNA, proteins, or other molecules on solid surfaces such as glass slides or silicon chips. These scanners are utilized to measure the fluorescent regions of DNA microarrays, providing detailed insights into the simultaneous activity of numerous genes.
The primary product categories of microarray scanners include fluorescence microarray scanners, charge-coupled device microarray scanners, colorimetric microarray scanners, and others. Fluorescence microarray scanners are specialized instruments designed for the detection and capture of fluorescent signals emitted by molecules labeled with fluorescence on microarrays. Microarray scanners utilize various technologies, including slide-based and gel-based approaches, with applications spanning gene expression, drug discovery, and more. The end users of these scanners are diverse and include hospitals, diagnostic laboratories, pharmaceutical and biotechnology companies, as well as academic and research institutes.
The microarray scanners market consists of sales of microarray slides, microarray printing and labeling kit, microarray scanners software and analysis tools, and microarray wash stations. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Microarray Scanners Market Characteristics
3. Microarray Scanners Market Supply Chain Analysis
4. Global Microarray Scanners Market Trends and Strategies
5. Microarray Scanners Market Analysis of End Use Industries
7. Global Microarray Scanners Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Microarray Scanners Total Addressable Market (TAM) Analysis for the Market
9. Microarray Scanners Market Segmentation
10. Microarray Scanners Market Regional and Country Analysis
11. Asia-Pacific Microarray Scanners Market
12. China Microarray Scanners Market
13. India Microarray Scanners Market
14. Japan Microarray Scanners Market
15. Australia Microarray Scanners Market
16. Indonesia Microarray Scanners Market
17. South Korea Microarray Scanners Market
18. Taiwan Microarray Scanners Market
19. South East Asia Microarray Scanners Market
20. Western Europe Microarray Scanners Market
21. UK Microarray Scanners Market
22. Germany Microarray Scanners Market
23. France Microarray Scanners Market
24. Italy Microarray Scanners Market
25. Spain Microarray Scanners Market
26. Eastern Europe Microarray Scanners Market
27. Russia Microarray Scanners Market
28. North America Microarray Scanners Market
29. USA Microarray Scanners Market
30. Canada Microarray Scanners Market
31. South America Microarray Scanners Market
32. Brazil Microarray Scanners Market
33. Middle East Microarray Scanners Market
34. Africa Microarray Scanners Market
36. Microarray Scanners Market Competitive Landscape and Company Profiles
37. Microarray Scanners Market Other Major and Innovative Companies
40. Microarray Scanners Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Microarray Scanners Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses microarray scanners market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for microarray scanners? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microarray scanners market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Fluorescence Microarray Scanners; Charge-Coupled Devices Microarray Scanners; Colorimetric Microarray Scanners; Other Product Types2) By Application: Gene Expression; Drug Discovery; Other Applications
3) By End User: Hospitals; Diagnostic Laboratories; Pharmaceutical And Biotechnology Companies; Academic And Research Institutes
Subsegments:
1) By Fluorescence Microarray Scanners: Laser Scanners; Multispectral Scanners2) By Charge-Coupled Devices (CCD) Microarray Scanners: Standard CCD Scanners; High-Resolution CCD Scanners
3) By Colorimetric Microarray Scanners: Slide Scanners; Digital Colorimetric Scanners
4) By Other Product Types: Hybrid Scanners; Custom Or Specialized Microarray Scanners
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; GE Healthcare Life Sciences; Hitachi High-Tech Corporation; Innopsys Inc.; PerkinElmer Inc.; VWR International LLC; Illumina Inc.; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Tecan Group AG; Huron Technologies International Inc.; Miltenyi Biotec B.V. & Co. KG; Luminex Corporation; Molecular Devices LLC; CapitalBio Technology Inc.; Berthold Technologies GmbH & Co. KG; RayBiotech Inc.; Scienion AG; Oxford Gene Technology IP Limited; Applied Microarrays Inc.; Arrayit Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Microarray Scanners market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- GE Healthcare Life Sciences
- Hitachi High-Tech Corporation
- Innopsys Inc.
- PerkinElmer Inc.
- VWR International LLC
- Illumina Inc.
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- Tecan Group AG
- Huron Technologies International Inc.
- Miltenyi Biotec B.V. & Co. KG
- Luminex Corporation
- Molecular Devices LLC
- CapitalBio Technology Inc.
- Berthold Technologies GmbH & Co. KG
- RayBiotech Inc.
- Scienion AG
- Oxford Gene Technology IP Limited
- Applied Microarrays Inc.
- Arrayit Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.08 Billion |
| Forecasted Market Value ( USD | $ 1.5 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
